Home Biosimilar Antibodies Others Others antibody Avdoralimab (Anti-Complement C5aR1) For research use only.
Not for use in humans.

Avdoralimab (Anti-Complement C5aR1)

Synonyms: IPH 5401; Anti-C5aR1 mAb

Avdoralimab (Anti-Complement C5aR1) is a fully human IgGκ monoclonal antibody targeting the complement C5a receptor 1 (C5aR1), that prevents its binding to C5a. Avdoralimab can be used for complement-driven inflammatory diseases and solid tumours research. MW: 145.5 KD.

Avdoralimab (Anti-Complement C5aR1)

Purity & Quality Control

≥99

Biological Activity

Description Avdoralimab (Anti-Complement C5aR1) is a fully human IgGκ monoclonal antibody targeting the complement C5a receptor 1 (C5aR1), that prevents its binding to C5a. Avdoralimab can be used for complement-driven inflammatory diseases and solid tumours research. MW: 145.5 KD.

Product Details

CAS No. 2226393-85-5
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Avdoralimab (Anti-Complement C5aR1) | Avdoralimab (Anti-Complement C5aR1) supplier | purchase Avdoralimab (Anti-Complement C5aR1) | Avdoralimab (Anti-Complement C5aR1) cost | Avdoralimab (Anti-Complement C5aR1) manufacturer | order Avdoralimab (Anti-Complement C5aR1) | Avdoralimab (Anti-Complement C5aR1) distributor